Filing Details
- Accession Number:
- 0001181431-11-012313
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-23 16:06:55
- Reporting Period:
- 2011-02-07
- Filing Date:
- 2011-02-23
- Accepted Time:
- 2011-02-23 16:06:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242215 | C Joseph Papa | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | President And Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-07 | 700 | $0.00 | 121,337 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2011-02-22 | 6,000 | $74.84 | 115,337 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-02-22 | 15,000 | $17.29 | 130,337 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-22 | 15,000 | $75.04 | 115,337 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-22 | 1,128 | $0.00 | 1,128 | $17.29 |
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-22 | 13,872 | $0.00 | 17,042 | $17.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-08-16 | 2016-08-16 | No | 4 | M | Direct |
| 3,170 | 2010-08-16 | 2016-08-16 | No | 4 | M | Direct |
Footnotes
- A Rule 10b5-1 sales plan adopted by the reporting person on February 7, 2011, is scheduled to sell shares on February 22, 2011, March 22, 2011 and April 22, 2011. This 10b5-1 sales plan will expire on the close of business April 22, 2011.
- The price in column 4 is a weighted average. The prices actually received ranged from $74.82 to $74.90. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $74.65 to $75.363. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
